Skip to main content
Monthly Archives

December 2018

Bellicum Pharmaceuticals: Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO

Bellicum Pharmaceuticals, Inc. Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO Rimiducid-activated GoCAR-T┬«┬áresulted in significant expansion and…

Read More